What is Iovance Biotherapeutics 12-1 Month Momentum %?
12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2025-04-24), Iovance Biotherapeutics's 12-1 Month Momentum % is -69.00%.
The industry rank for Iovance Biotherapeutics's 12-1 Month Momentum % or its related term are showing as below:
IOVA's 12-1 Month Momentum % is ranked worse than 83.78% of 1443
companies
in the Biotechnology industry
Industry Median: -19.6
vs IOVA: -69.00
Competitive Comparison of Iovance Biotherapeutics's 12-1 Month Momentum %
For the Biotechnology subindustry, Iovance Biotherapeutics's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Iovance Biotherapeutics's 12-1 Month Momentum % Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Iovance Biotherapeutics's 12-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where Iovance Biotherapeutics's 12-1 Month Momentum % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
Iovance Biotherapeutics 12-1 Month Momentum % Related Terms
Thank you for viewing the detailed overview of Iovance Biotherapeutics's 12-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.
Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
IOVA has been successfully added to your